Form 4: Achieve Life Sciences Director Acquires Stock Options

Achieve Life Sciences, Inc. reports that Director Reid Alexander acquired stock options with an exercise price of $5.24, vesting over 36 months.

Summary

• Reid Alexander, a Director at Achieve Life Sciences, Inc., was granted stock options on May 29, 2026.
• The options have an exercise price of $5.24 per share.
• A total of 47,250 stock options were granted.
• These options will vest in substantially equal monthly installments over 36 months, starting May 29, 2026.
• Vesting is contingent upon Mr. Alexander's continued service to the Issuer on each vesting date.
• Following the transaction, Mr. Alexander beneficially owns 47,250 shares of common stock directly.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it represents standard compensation practices for a director and indicates continued engagement, but does not provide new financial performance data.

Positives

• Director Reid Alexander's acquisition of stock options aligns his interests with shareholders, indicating confidence in the company's future prospects.
• The vesting schedule over 36 months incentivizes long-term commitment and performance from the director.

Negatives

• The filing does not contain any negative financial results or operational setbacks.

Risks

• The value of the stock options is subject to market fluctuations and the company's future performance.
• Continued service is a condition for vesting, meaning any departure from the company before vesting completion would result in forfeiture of unvested options.

Future Outlook

The stock options granted to Director Reid Alexander suggest a positive outlook for the company, as they are tied to future performance and continued service.

Industry Context

StockSavvy.ai notes that the granting of stock options to directors is a common practice in the biotechnology and life sciences sector to attract and retain key talent and align executive interests with shareholder value.

Stakeholder Impact

• Shareholders: The alignment of director interests with company performance through stock options can be viewed positively, potentially leading to decisions that enhance shareholder value.
• Employees: Standard compensation practices for directors can contribute to overall company morale and stability.
• Management: Reinforces the importance of director commitment and performance for compensation.

Next Steps

• Director Reid Alexander will continue to provide service to Achieve Life Sciences, Inc. to meet the vesting conditions of the stock options.
• The stock options will vest monthly over 36 months, commencing May 29, 2026.

Key Dates

Keywords

Form 4, SEC Filing, Achieve Life Sciences, ACHV, Stock Options, Director Compensation, Beneficial Ownership, Insider Trading, Vesting Schedule